Log in

NYSE:SNNSmith & Nephew Stock Price, Forecast & News

$39.42
-0.26 (-0.66 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$39.36
Now: $39.42
$39.96
50-Day Range
$37.62
MA: $40.55
$44.24
52-Week Range
$26.07
Now: $39.42
$52.26
Volume598,400 shs
Average Volume783,338 shs
Market Capitalization$17.26 billion
P/E Ratio19.32
Dividend Yield2.28%
Beta0.56
Smith & Nephew plc develops, manufactures, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. Additionally, it offers meniscal repair system. It primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.
Read More
Smith & Nephew logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.1Community Rank: 1.8Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.65 out of 5 stars


Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone44-19-2347-7100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.14 billion
Cash Flow$3.17 per share
Book Value$11.76 per share

Profitability

Miscellaneous

Employees17,637
Market Cap$17.26 billion
Next Earnings DateN/A
OptionableOptionable

Receive SNN News and Ratings via Email

Sign-up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter.

Smith & Nephew (NYSE:SNN) Frequently Asked Questions

How has Smith & Nephew's stock been impacted by COVID-19 (Coronavirus)?

Smith & Nephew's stock was trading at $38.73 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SNN stock has increased by 1.8% and is now trading at $39.42. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Smith & Nephew?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 2 sell ratings, 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Smith & Nephew.

How were Smith & Nephew's earnings last quarter?

Smith & Nephew plc (NYSE:SNN) issued its quarterly earnings data on Monday, November, 17th. The medical equipment provider reported $0.98 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.39 by $0.59. View Smith & Nephew's earnings history.

How often does Smith & Nephew pay dividends? What is the dividend yield for Smith & Nephew?

Smith & Nephew announced a semi-annual dividend on Monday, February 24th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.462 per share on Wednesday, May 6th. This represents a dividend yield of 1.4%. The ex-dividend date of this dividend is Thursday, April 2nd. View Smith & Nephew's dividend history.

What price target have analysts set for SNN?

8 equities research analysts have issued 1 year price targets for Smith & Nephew's shares. Their forecasts range from $42.00 to $42.00. On average, they expect Smith & Nephew's stock price to reach $42.00 in the next year. This suggests a possible upside of 6.5% from the stock's current price. View analysts' price targets for Smith & Nephew.

Has Smith & Nephew been receiving favorable news coverage?

Media coverage about SNN stock has been trending somewhat positive recently, InfoTrie reports. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Smith & Nephew earned a media sentiment score of 0.7 on InfoTrie's scale. They also assigned media coverage about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Smith & Nephew.

Are investors shorting Smith & Nephew?

Smith & Nephew saw a decline in short interest during the month of June. As of June 15th, there was short interest totaling 922,600 shares, a decline of 6.5% from the May 31st total of 986,600 shares. Based on an average daily volume of 922,700 shares, the days-to-cover ratio is presently 1.0 days. Approximately 0.2% of the shares of the company are sold short. View Smith & Nephew's Current Options Chain.

Who are some of Smith & Nephew's key competitors?

What other stocks do shareholders of Smith & Nephew own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Alexion Pharmaceuticals (ALXN) and Amgen (AMGN).

Who are Smith & Nephew's key executives?

Smith & Nephew's management team includes the following people:
  • Mr. Namal Nawana, CEO & Exec. Director (Age 48)
  • Mr. Graham Timothy Baker, CFO & Exec. Director (Age 51)
  • Mr. Mark Gladwell, Pres of Global Operations (Age 44)
  • Ms. Catheryn O'Rourke, Chief Legal & Compliance Officer (Age 46)
  • Mr. Joe Metzger, Sr. VP of Marketing Services & Communications

What is Smith & Nephew's stock symbol?

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

How do I buy shares of Smith & Nephew?

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Smith & Nephew's stock price today?

One share of SNN stock can currently be purchased for approximately $39.42.

How big of a company is Smith & Nephew?

Smith & Nephew has a market capitalization of $17.26 billion and generates $5.14 billion in revenue each year. The medical equipment provider earns $600 million in net income (profit) each year or $2.04 on an earnings per share basis. Smith & Nephew employs 17,637 workers across the globe.

What is Smith & Nephew's official website?

The official website for Smith & Nephew is www.smith-nephew.com.

How can I contact Smith & Nephew?

Smith & Nephew's mailing address is BUILDING 5 CROXLEY PARK HATTERS LANE, WATFORD X0, WD18 8YE. The medical equipment provider can be reached via phone at 44-19-2347-7100 or via email at [email protected]

This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.